Ortho Biological Products Market Growth, Size, Share, Industry Report and Forecast 2021-2027

The global ortho biological products market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Orthobiologics are substances that are used to heal injury rapidly and are derived from a patient's tissues, such as bone marrow or blood that are filled with signalling molecules or cells. These products improve the healing of broken bones and injured muscles, tendons, and ligaments. The major factor supporting the growth of the market is the new product launches and FDA approvals.

For instance, in September 2021, Royal Biologics announced that FDA has approved their Maxx- PRP a patented next-generation concentration device that is used to concentrate autologous whole blood. It is used for the safe and rapid preparation of platelet-rich plasma to use point of care for mixing with autograft and/or allograft to improve handling characteristics. Additionally, in January 2021, Surgalign Holdings Inc. announced the commercial launch and the completion of the first surgery of ViBone Moldable in the US. ViBone Moldable is the newest orthobiologics solution that supports spinal fusion. Hence, the new product launches and FDA approvals are driving the demand for ortho biological products which is driving the market growth.

To Request a Sample of our Report on Ortho Biological Products Market: https://www.omrglobal.com/request-sample/ortho-biological-products-market

Some major players in the market include Baxter International Inc., Johnson & Johnson Services, Inc., and Medtronic plc, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in December 2020, Fuse Medical, Inc. announced the initial launch of FuseChoice and FuseChoice Plus Amniotic & Umbilical Membranes, and FuseChoice Plus Amniotic Joint Cushioning Fluid. These are a comprehensive line of biologics products offered by the company.

Market Coverage

• The market number available for - 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

Segment Covered-

· By Type

· By Application

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

• Competitive Landscape- Baxter International Inc., Johnson & Johnson Services, Inc., and Medtronic plc, among others.



(Get 15% Discount on Buying this Report)

A full Report of Ortho Biological Products Market is Available @ https://www.omrglobal.com/industry-reports/ortho-biological-products-market

Global Ortho Biological Products Market Report by Segment

By Type

• DBM

• Allograft

• BMP

• Viscosupplementation

• Machined Bones

• Others

By Application

• Trauma

• Spinal Fusion

• Reconstructive Surgeries

• Tendon & Ligament Repair

• Others

Global Ortho Biological Products Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.